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Abstract
Objective
To examine the internal consistency and distribution of the Yale Global Tic Severity Scale
(YGTSS) scores to inform modiﬁcation of the measure.
Methods
This cross-sectional study included 617 participants with a tic disorder (516 children and 101
adults), who completed an age-appropriate diagnostic interview and the YGTSS to evaluate tic
symptom severity. The distributions of scores on YGTSS dimensions were evaluated for
normality and skewness. For dimensions that were skewed across motor and phonic tics,
a modiﬁed Delphi consensus process was used to revise selected anchor points.
Results
Children and adults had similar clinical characteristics, including tic symptom severity. All
participants were examined together. Strong internal consistency was identiﬁed for the YGTSS
Motor Tic score (α = 0.80), YGTSS Phonic Tic score (α = 0.87), and YGTSS Total Tic score
(α = 0.82). The YGTSS Total Tic and Impairment scores exhibited relatively normal
distributions. Several subscales and individual item scales departed from a normal distribution.
Higher scores were more often used on the Motor Tic Number, Frequency, and Intensity
dimensions and the Phonic Tic Frequency dimension. By contrast, lower scores were more
often used on Motor Tic Complexity and Interference, and Phonic Tic Number, Intensity,
Complexity, and Interference.
Conclusions
The YGTSS exhibits good internal consistency across children and adults. The parallel ﬁndings
across Motor and Phonic Frequency, Complexity, and Interference dimensions prompted
minor revisions to the anchor point description to promote use of the full range of scores in
each dimension. Speciﬁc minor revisions to the YGTSS Phonic Tic Symptom Checklist were
also proposed.
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Glossary
ADHD = attention-deﬁcit/hyperactivity disorder; ADIS-C/P = Anxiety Disorder Interview Schedule–Parent and Child
Version; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, 4th edition; K-SADS = Kiddie-Schedule for Aﬀective
Disorders; MINI-KID = Mini International Neuropsychiatric Interview-KID; OCD = obsessive-compulsive disorder; RCT =
randomized clinical trial; SCID = Structured Clinical Interview for DSM-IV; TD = Tourette disorder; YGTSS = Yale Global Tic
Severity Scale; YGTSS-R = Yale Global Tic Severity Scale–Revised.

Empirically supported interventions for Tourette disorder
(TD) have been established in randomized clinical trials
(RCTs). Entry criteria in RCTs and treatment guidelines rely
on accurate assessment of tic severity for participant selection
and empirically supported treatment recommendations.1–3
Thus, optimal precision in measuring tic severity is essential
for clinical care and research. The Yale Global Tic Severity
Scale (YGTSS) is a multidimensional, clinician-rated scale
that measures tic severity4 and is commonly used as a primary
outcome measure in RCTs.5–7,17 There have been 5 published
psychometric evaluations of the YGTSS.4,8–11 These studies
have shown that the YGTSS Total Tic score has excellent
internal consistency (α = 0.93–0.99),8,12 excellent interrater
reliability (intraclass correlations = 0.84–0.95),4,12 and good
test–retest reliability.8 The YGTSS Total Tic score has also
demonstrated good convergent validity4,8 and discriminant
validity from measures of anxiety, depression, attentiondeﬁcit/hyperactivity disorder (ADHD) severity, and
obsessive-compulsive disorder (OCD) (r = 0.01–0.36).4,8
Finally, the motor and vocal, 2-factor structure has been
supported in all 5 studies.4,8,10–12
Despite their strengths, these prior reports have been relatively small, single-site studies, which limits the generalization
of the ﬁndings. Moreover, the small sample sizes do not allow
detailed examination of the scale dimensions. This report
examines the internal consistency and distribution of YGTSS
component scores and dimensions in a large, multisite sample
of children and adults. Based on these ﬁndings, strategic
revisions are oﬀered designed to increase the precision of the
YGTSS.

Methods
Participants
Participants included 617 individuals diagnosed with a DSMIV tic disorder (552 Tourette syndrome, 46 chronic motor tic
disorder, 5 chronic vocal tic disorder, and 14 transient tic
disorder) that were recruited from 7 US academic TD and
OCD specialty clinics. Participants were ascertained in routine clinical care or via participation in a clinical trial (University of California Los Angeles, n = 181; University of South
Florida, n = 207; University of Wisconsin–Milwaukee, n = 66;
Massachusetts General Hospital and Harvard Medical School,
n = 47; John Hopkins University, n = 41; University of Texas
Health Science Center at San Antonio, n = 40; Yale Child
Study Center, n = 35).5,6,13–19 The sample was predominantly
e1712
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male and Caucasian (see table 1 for demographic and clinical
characteristics). The average age of participants was 15 ± 10
years (range 5–69). Co-occurring psychiatric conditions were
common, with 64% of participants meeting diagnostic criteria
for one or more of the following disorders: ADHD, OCD,
non-OCD anxiety disorders, and depressive disorders.
Measures
Psychiatric diagnoses

Psychiatric diagnoses were determined by an experienced
multidisciplinary team at each site (e.g., child psychiatrist,
psychologist, psychiatric nurse practitioner). In 410 (66.4%)
cases, the clinical assessment was supported by an ageappropriate structured diagnostic interview administered by
a trained clinician (i.e., Anxiety Disorder Interview
Schedule–Parent and Child Version [ADIS-C/P],20,21 n =
157; the Structured Clinical Interview for DSM-IV [SCID],22
n = 122; Kiddie-Schedule for Aﬀective Disorders [K-SADS],
n = 106; Mini International Neuropsychiatric Interview-KID
[MINI-KID],23 n = 25). In the remaining 207 cases, 2
doctoral-level psychologists or child psychiatrists applied
a best estimate procedure to establish consensus on diagnoses
using all available information.24
Yale Global Tic Severity Scale

The YGTSS is a clinician-rated measure of tic severity over the
last 7–10 days that has a stable factor structure9 and excellent
psychometric properties.4,8 The motor and phonic tics are
rated separately on a 0–5 scale across 5 dimensions: number,
frequency, intensity, complexity, and interference. Although
motor and phonic tics are rated separately, the anchor point
descriptions used to guide scoring are the same for both
motor and phonic domains. The scores from each dimension
(number, frequency, intensity, complexity, and interference)
are summed to produce the Total Motor Tic score (range
0–25), the Total Phonic Tic score (range 0–25), and the
combined Total Tic score (range 0–50). The scale also
includes a separate Impairment scale that reﬂects overall ticrelated impairment (range 0–50).
Procedures
Standard protocol approvals, registrations, and
patient consents

Local institutional review boards approved all study procedures for each research protocol. After explaining study procedures, adult participants provided consent and a parent
provided permission for minors (with minor assent).
Neurology.org/N
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Table 1 Participant characteristics and comparison of child and adult participants
Total sample
(n = 617), n (%)

Child participants
(n = 516), n (%)

Adult participants
(n = 101), n (%)

Effect size

Male

441 (71.5)

380 (73.6)

61 (60.4)

0.11b

White

474 (76.8)

393 (76.1)

81 (80.2)

0.04

Hispanic

79 (12.8)

66 (12.8)

13 (12.9)

<0.01

Asian/Pacific Islander

26 (4.2)

21 (4.1)

5 (5)

0.02

African American

12 (1.9)

11 (2.1)

1 (1)

0.03

Other

13 (2.1)

12 (2.3)

1 (1)

0.03

13 (2.1)

13 (2.5)

0 (0)

0.07

ADHD

209 (33.9)

183 (35.5)

26 (25.7)

0.08

OCD

168 (27.2)

151 (29.3)

17 (16.8)

0.10b

Anxiety disorder

215 (34.8)

197 (38.2)

18 (17.8)

0.16c

Depressive disorder

38 (6.2)

31 (6.0)

7 (6.9)

0.01

Mean (SD)

Mean (SD)

Mean (SD)

d

Age

15.13 (10.43)

11.32 (2.76)

34.64 (13.11)

3.98c

YGTSS Motor Total score

14.37 (4.45)

14.21 (4.65)

15.16 (3.17)

0.21d

YGTSS Phonic Total score

9.35 (5.45)

9.67 (5.44)

7.70 (5.20)

0.36c

YGTSS Total Tic score

23.71 (7.84)

23.88 (8.04)

22.86 (6.71)

0.13

YGTSS Impairment score

22.90 (10.94)

22.61 (11.58)

24.38 (6.23)

0.16

Demographics

Unknown
Co-occurring disorders

a

Abbreviations: ADHD = attention-deficit/hyperactivity disorder; OCD = obsessive-compulsive disorder; YGTSS = Yale Global Tic Severity Scale.
a
Included only current psychiatric diagnoses, not lifetime. ADHD included inattentive type, hyperactive type, and combined type. Anxiety disorders included
separation anxiety, social phobia, generalized anxiety, specific phobia, panic disorder, agoraphobia, and anxiety disorders not otherwise specified. Depressive disorders included major depressive disorder, dysthymia, or depressive disorder not otherwise specified.
b
p < 0.01.
c
p < 0.001.
d
p < 0.05.

Participants (and their parents for youth) completed
clinician-administered measures to assess psychiatric diagnoses (ADIS-C/P, SCID, K-SADS, MINI-KID, or clinical
interview). The same or another clinician trained to reliability
administered the YGTSS to assess tic symptom severity.
Supervision on assessments varied slightly across protocols.
However, all raters received regular supervision from investigators with extensive TD assessment experience at the local
study site, or, for multisite trials, through monthly teleconference calls.
Analytic plan
First, descriptive statistics characterized the demographics,
co-occurring psychiatric conditions, tic symptom severity, and
tic-related impairment of the sample. Second, to check for age
diﬀerences, χ 2 and t tests compared clinical and demographic
diﬀerences between youth and adults. p Values and eﬀect sizes
were calculated (Cramer V for categorical and Cohen d for
continuous comparisons). Third, Cronbach α examined the
Neurology.org/N

internal consistency of the YGTSS Motor Tic score, YGTSS
Phonic Tic score, YGTSS Total Tic score, and YGTSS Total
Tic and Impairment score. Fourth, we examined the distribution of the Total Motor, Total Phonic, and Total Tic scores,
the Impairment score, and individual YGTSS severity items.
For an initial evaluation on the normality of these individual
and summary scores, we used Kolmogorov-Smirnov and
Shapiro-Wilk tests. Because these normality tests may be
unreliable for larger sample sizes,25 we also used z scores to
identify the magnitude of skewness (i.e., degree of asymmetry
in the distributions). z Scores larger than 1.96 were considered signiﬁcant. Negatively skewed distributions have a longer
tail on the left that indicates more frequent use of higher
scores (i.e., the median > mean). By contrast, positively
skewed distributions have a longer tail on the right, reﬂecting
more frequent use of lower scores (median < mean). Means,
SDs, and distributions were examined to develop suggestions
on strategic revisions of the YGTSS. Using a modiﬁed Delphi
method, consensus was achieved through an iterative
Neurology | Volume 90, Number 19 | May 8, 2018
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process.26 The measurement concerns and initial anchor
point revisions were proposed by 2 study authors (J.F.M.,
L.S.). These concerns and proposals were independently
reviewed by a panel of experts (other authors of this report).
Expert panel members then provided independent comments
and feedback that were integrated and summarized into
a second and third round of anchor point revisions. The panel
approved the appropriateness of the ﬁnal set of revisions.
Data availability
Study data for the primary analyses presented in this report
are available upon reasonable request from the corresponding
and senior author.

Results
Participants
Table 1 presents the demographic and clinical characteristics
of the sample. Compared to the adult sample (≥18 years),
youth <18 years of age had a higher proportion of male participants, higher prevalence of OCD and anxiety disorders,
and a 2-point higher mean score on Total Phonic Tic score.
Other than these minor diﬀerences, the adult and pediatric
samples were similar. Thus, the adult and pediatric samples
were combined.
Internal consistency of YGTSS summary scores
The internal consistency for Total Motor, Total Phonic, and
Total Tic scores suggested solid coherence of the subscale
scores and the Total Tic score (table 2).27 In addition, one-byone removal of individual dimension scores produced internal
consistencies that suggest that no single item was a threat to
the overall internal consistency of the scale (table 2).
Distribution of YGTSS scores
Table 3 presents the descriptive statistics and distribution for
YGTSS Total Motor, Total Phonic, and Total Tic Impairment
scores, and individual YGTSS dimension scales (ﬁgure e-1,
links.lww.com/WNL/A422, presents distribution of Impairment scores). Using a z score of 1.96 to deﬁne skewness, the
Total Phonic Tic score, Total Tic score, and Impairment score
did not depart from a normal distribution. The Total Motor
Tic score showed a negative skew (infrequent use of lower
scores). At the individual dimension level, all 5 Motor scores
and all 5 Phonic scores were signiﬁcantly skewed (table 3 and
ﬁgure 1). Across the Motor and Phonic dimensions, both
positive and negative skewness were observed. Furthermore,
some Motor Tic and Phonic Tic dimensions were skewed in
opposite directions (e.g., Motor and Phonic Number dimension). Because anchor point descriptions serve the same
Motor and Phonic tic dimension, any revision to the anchor
point description could have contrary eﬀects. For example,
a revision to the Number dimension would have opposing
eﬀects on Motor and Phonic tic severity. As shown in table 3, 3
dimensions (Frequency, Complexity, and Interference) were
signiﬁcantly skewed in the same direction across Motor and
e1714
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Table 2 Internal consistencies of Yale Global Tic Severity
Scale (YGTSS) scores (n = 617)
Coefficient α
YGTSS Total Tic score and
Impairment score

0.67

YGTSS Total Tic score

0.82

Coefficient α,
if item removed

Motor Number

0.80

Motor Frequency

0.82

Motor Intensity

0.81

Motor Complexity

0.80

Motor Interference

0.81

Phonic Number

0.79

Phonic Frequency

0.81

Phonic Intensity

0.79

Phonic Complexity

0.80

Phonic Interference

0.79

YGTSS Motor Tic score

0.80

Number

0.73

Frequency

0.79

Intensity

0.76

Complexity

0.76

Interference

0.77

YGTSS Phonic score

0.87

Number

0.82

Frequency

0.85

Intensity

0.81

Complexity

0.87

Interference

0.84

Phonic tic dimensions. The Frequency dimension was negatively skewed for Motor and Phonic tic dimensions (infrequent use of lower scores). Complexity and Interference
were positively skewed for Motor and Phonic dimensions
(infrequent use of higher scores). Based on these observations,
the following minor revisions to the YGTSS Frequency,
Complexity, and Interference dimensions were undertaken.
Standardization of anchors across dimensions

To support consistency across dimensions, we suggest using
the same qualitative designations: none, minimal, mild,
moderate, marked, and severe for scores of 0–5, respectively.
Tic Frequency dimension

As shown in table 3, the mean score for Motor Frequency was
4.08 and Phonic Frequency was 3.00. Although a score of 1
Neurology.org/N
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Table 3 Distribution of Yale Global Tic Severity Scale scores across participants (n = 617)
Mean (SD)

Mode/median

Range

Interquartile range

Skew

Skew z

Direction

Total Tic Severity score

23.71 (7.84)

22/24

4–50

10

0.17

1.72

None

Total Impairment score

22.90 (10.94)

20/20

0–50

10

−0.19

1.94

None

Total Motor Tic score

14.37 (4.45)

16/15

0–25

5

−0.58

5.82

Negative

Number

3.13 (1.21)

4/3

0–5

2

−0.33

3.39

Negative

Frequency

4.08 (1.14)

5/4

0–5

1

−1.54

15.72

Negative

Intensity

2.98 (1.00)

3/3

0–5

2

−0.26

2.65

Negative

Complexity

2.10 (1.38)

3/2

0–5

2

−0.21

2.14

Positive

Interference

2.08 (1.21)

1/2

0–5

2

0.55

5.56

Positive

9.35 (5.45)

0/10

0–25

6

−0.11

1.08

None

Number

1.70 (1.12)

2/2

0–5

1

0.53

5.45

Positive

Frequency

3.00 (1.72)

4/4

0–5

2

−0.58

5.95

Negative

Intensity

2.19 (1.25)

2/2

0–5

1

−0.30

3.05

Positive

Complexity

0.97 (1.37)

0/0

0–5

2

1.13

11.55

Positive

Interference

1.49 (1.19)

1/1

0–5

1

0.86

8.77

Positive

Total Phonic Tic score

Positive skew indicates greater use of lower scale scores. Negative skew indicates greater use of higher scores.

was rarely used, scores of 4 and 5 predominate (ﬁgure 1).
These observations are consistent with the signiﬁcant negative skew of this dimension (infrequent use of lower scores).
Based on these observations, the anchor point description for
the score of 1 on the Frequency dimension was dropped. In
the revised set of anchor points (table 4 and table e-1, links.
lww.com/WNL/A423), the 3 key elements of the Frequency
dimension (duration of tic-free intervals, frequency of tic
bouts, and whether the bouts of tics occur in 1 or more
settings) are presented incrementally for scores 1–5. The
phrase in the original anchor description “periods of sustained
bouts” has been removed from descriptions of moderate or
marked, as it is arguable that the expression “sustained bouts”
is captured in the Complexity dimension.

for ratings of marked and severe (scores of 4 and 5, respectively). Scores of marked and severe are delineated by the
presence of behavior that could or could not be explained as
normal behavior due to the extreme nature of the behavior.
Tic Interference dimension

The Interference dimension turns on 2 elements: whether tics
interrupt the ﬂow of behavior or speech and whether tics
actually disrupt intended action or speech. The descriptions
for minimal and mild items were not changed. However, to
distinguish the anchor point for moderate, we added the
phrase “but do not disrupt intended behavior or speech”
(table 4). Descriptions of marked and severe were not
changed.

Tic Complexity dimension

Tic Number dimension

The original description for a Complexity score of zero read
“If present, all tics are clearly ‘simple’ (sudden, brief, purposeless) in character.” This description is unlike any other
zero score on YGTSS dimensions, where a score of zero is
“none” or “no tics present.” To match the other dimensions,
we inserted “No tics present” for the Complexity score of
0 (tables 4 and e-1). This should remedy the high frequency of
zeros for the Motor and Phonic Complexity items (ﬁgure 1).
The former description of 0 (i.e., “If present, all tics are clearly
‘simple’ [sudden, brief, purposeless] in character”) is now
aligned with a score of 1 (minimal); the former description for
a score of 1 (borderline) is now aligned with a score of 2. The
description of moderate (score of 3) is similar to the original,
except that the wording “may occur in orchestrated bouts”
was removed. The mention of orchestrated bouts is reserved

The Number dimension showed a negative skew for Motor
(infrequent use of lower scores) and a positive skew for
Phonic (infrequent use of higher scores). Thus, anchor point
revision would not be useful. As shown in ﬁgure 1, the 2 most
common Phonic Tic Number scores in this sample were 1
(single phonic tic) or 2 (2–5 multiple discrete tics). The score
of 3 (>5 multiple discrete tics) was rarely used. Although it
may be possible that individuals with TD have a greater diversity of motor tics than phonic tics, the diﬀerence in the
Number scores may be attributed to the limited number of
examples on the YGTSS Phonic Tic Symptoms Checklist. In
addition, some entries on the Phonic Symptom Checklist are
categories rather than separate tics (e.g., animal noises rather
than a list of speciﬁc noises). By contrast, the Motor Symptom
Checklist is more detailed. In order to reduce the diﬀerences

Neurology.org/N
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Figure 1 Distribution of Yale Global Tic Severity Scale item
scores in the sample of 617 children and adults
with tic disorders

Discussion
This article examines the internal consistency and distribution
of YGTSS tic severity scores in a well-characterized sample of
children and adults with TD. To our knowledge, this is the
largest sample of participants with TD evaluated using the
YGTSS. Consistent with prior research,28 only minor diﬀerences between children and adults with TD were observed.
The YGTSS Total Motor Tic score, Total Phonic Tic score,
and Total Tic score showed good internal consistency across
component scales (α values ranged from 0.82 to 0.87), and no
improvement in internal consistency was observed if a speciﬁc
item was removed from the scale. These observations are
consistent with prior reports.4,8,10–12 Thus, the ﬁndings support the internal consistency of the YGTSS, and support
its use as a measure of tic symptom severity in children
and adults.
The overall aim of the minor anchor point revisions to the
YGTSS was to promote use of the entire range of these scales.
For the negatively skewed distribution of Motor and Phonic
Tic Frequency (infrequent use of lower scores), revisions to
the anchor point descriptions are intended to promote use of
lower severity scores on these dimensions (table 4). Brieﬂy,
the description for a score of 1 was dropped and a more severe
description was provided for the score of 5. Scores in between
1 and 5 were dropped 1 unit without changing the anchor
point descriptions. To repair the positively skewed distribution of the Motor and Phonic Tic Complexity dimension
(infrequent use of higher scores), we revised the score of zero
to be consistent with all other YGTSS dimensions to read “no
tics present.” This revision shifted the former anchor point
descriptions upward by 1 unit, and called for minor clariﬁcation to diﬀerentiate scores for 4 and 5. Finally, the positively
skewed distribution of the Motor and Phonic Tic Interference
dimension implied that the anchor points needed revision to
capture incremental description on interruption and disruption of intended behavior and speech. These proposed minor
revisions are oﬀered to improve the precision of the YGTSS,
and do not controvert the reliability and validity of ﬁndings
from prior studies using this measure. Based on discussion
and ﬁnal consensus of our expert panel, the revised YGTSS
(referred to as the YGTSS-Revised [YGTSS-R]) is recommended for use in clinical practice and research. A copy of the
YGTSS-R can be obtained online or from J.F.L. or L.S.

(A) Motor Tic scale. (B) Phonic Tic scale.

between Motor and Phonic Checklists, the revised YGTSS
includes a longer list of phonic tic symptoms based on
commonly endorsed tics in the Comprehensive Behavioral
Intervention for Tics trials (e.g., snorting, gulping, whistling).
Rater training should remind clinicians that each phonic tic
should be counted separately when making ratings on the
Number dimension.
e1716
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These study ﬁndings need to be considered in light of several
limitations. First, these participants were recruited from TD
and OCD specialty clinics and may not generalize to the wider
populations with TD. Second, the sample consisted primarily
of patients with TD, which may have contributed to the use of
higher scores on some YGTSS dimensions. However, our
sample appears similar to samples in prior psychometric
evaluations of the YGTSS. Thus, our sample appears representative of cases in clinical practice. Finally, although YGTSS
raters were trained to reliability, we did not examine interrater
or test–retest reliability across sites and raters.
Neurology.org/N
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Table 4 Proposed revisions to Yale Global Tic Severity Scale anchors for frequency, complexity, and interference
Rating
Frequency
None: No specific evidence of tics.

0

Minimal: Specific tics are usually present on a daily basis, but there are long tic-free intervals during the day. Bouts of tics may
occur on occasion, but are not sustained for more than a few minutes at a time.

1

Mild: Specific tics are present on a daily basis. Tic-free intervals as long as 3 hours are not uncommon. Bouts of tics occur
regularly, but generally limited to a single setting.

2

Moderate: Specific tics are present virtually every waking hour of every day. Bouts of tics are common and may not be limited to
a single setting.

3

Marked: Specific tics are present every waking hour. Bouts of tics are common and may occur in multiple settings.

4

Severe: Specific tics are present virtually all the time. Tic-free intervals are difficult to identify and do not last more than 5–10
minutes. Bouts of tics are very common and occur in multiple settings.

5

Complexity
None: No tics present.

0

Minimal: If present, all tics are clearly “simple” (sudden, brief, purposeless) in character.

1

Mild: Some tics are not clearly “simple” in character.

2

Moderate: Some tics are clearly “complex” (purposive in appearance) and mimic brief “automatic” behaviors, such as grooming,
syllables, or brief meaningful utterances such as “ah huh,” “hi” that could be camouflaged.

3

Marked: Some tics are more “complex” (more purposive and sustained in appearance) and may occur in orchestrated bouts that
would be difficult to camouflage but could be rationalized or “explained” as normal behavior or speech (tapping, saying “you
bet” or “honey,” “FF,” “sh,” brief echolalia).

4

Severe: Some tics are very “complex” in character and tend to occur in sustained orchestrated bouts that would be difficult to
camouflage and could not be easily rationalized as normal behavior or speech because of their duration or their unusual,
inappropriate, bizarre, or obscene character (a lengthy facial contortion, touching genitals, echolalia, speech atypicalities, bouts of
copropraxia, self-abusive behavior, or coprolalia).

5

Interference
None: No tics present.

0

Minimal: When tics are present, they do not interrupt the flow of behavior or speech.

1

Mild: When tics are present, they occasionally interrupt the flow of behavior or speech.

2

Moderate: When tics are present, they frequently interrupt the flow of behavior or speech, but do not disrupt intended behavior
or speech.

3

Marked: When tics are present, they frequently interrupt the flow of behavior or speech, and they occasionally disrupt intended
action or communication.

4

Severe: When tics are present, they frequently disrupt intended action or communication.

5

The YGTSS is the most commonly accepted outcome measure for tic symptom severity in children and adults with TD.
The proposed revisions to the YGTSS do not change the
overall architecture of the scale, or controvert the reliability
and validity of the original scale. These strategic revisions
expand the Phonic Tic Symptom Checklist and anchor points
for 3 YGTSS dimensions to promote full use of scales for
these dimensions.
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Study question
Are Yale Global Tic Severity Scale (YGTSS) subscales internally consistent and appropriately distributed?

Table Internal consistencies of YGTSS scale scores
YGTSS score type

α Coefficient

Summary answer
YGTSS subscale scores exhibit high internal consistency,
but had a skewed distribution for Frequency, Complexity,
and Interference dimensions. The skewed distributions
of these subscales guided the strategic revision of the
YGTSS.

Total Tic score and Impairment score

0.67

Total Tic score

0.82

Motor Tic score

0.80

Phonic Tic score

0.87

What is known and what this paper adds
Previous small, single-site studies of YGTSS Total Tic Scores
have reported high internal consistency, interrater reliability,
and test-retest reliability, but these studies could not adequately evaluate YGTSS component scores. This large, multisite study evaluated the component scores.

Although the study found no departures from normality in
the distributions of YGTSS Total Tic scores (z = 1.72) and
Total Impairment scores (z = 1.94), analyses of speciﬁc
dimensions revealed that higher scores were more often
used on the Frequency dimension (z = 5.95–15.72). By
contrast, lower scores were more often used on the Complexity dimension (z = 2.14–11.55) and Interference dimension (z = 5.56–8.77).

Participants and setting
This study recruited 617 participants with tic disorders
(71.5% men; mean age, 15 ± 10 years; age range, 5–69 years)
from 7 US academic centers specializing in tic disorders and
obsessive-compulsive disorder.
Design, size, and duration
The YGTSS was administered by clinicians trained to reliability.
Primary outcomes
The primary outcomes were the internal consistency and
distribution of YGTSS dimension scores (Number, Frequency, Intensity, Complexity, and Interference). Deviation
from normality was deﬁned as a z score >1.96.
Main results and the role of chance
This study detected high internal consistency for YGTSS
Total Tic score, and Motor Tic and Phonic Tic subscales.

Bias, confounding, and other reasons
for caution
This study did not assess test-retest reliability or site diﬀerences.
Generalizability to other populations
The generalizability of the results to the wider population of
patients with tic disorders may be limited due to the ascertainment from specialty centers and most (552/617; 89.5%) participants have a diagnosis of Tourette syndrome.
Study funding/potential competing interests
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